Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > PARAFAC2 and MCR-ALS quantification of Diltiazem antihypertensor based on a kinetic spectrophotometric methodology
Publication

Publications

PARAFAC2 and MCR-ALS quantification of Diltiazem antihypertensor based on a kinetic spectrophotometric methodology

Title
PARAFAC2 and MCR-ALS quantification of Diltiazem antihypertensor based on a kinetic spectrophotometric methodology
Type
Article in International Scientific Journal
Year
2007
Authors
leitao, jmm
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
da silva, jcge
(Author)
FCUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Journal
Vol. 89
Pages: 90-96
ISSN: 0169-7439
Publisher: Elsevier
Scientific classification
FOS: Engineering and technology > Electrical engineering, Electronic engineering, Information engineering
Other information
Authenticus ID: P-004-69J
Abstract (EN): A Diltiazem kinetic spectrophotornetric UV-Vis method, based on a reaction of the Diltiazem with hidroxylamine and a ferric salt, was used for the quantification of Diltiazem in different pharmaceutical formulations. This method is based on the acquisition of three-way data structures [wavelength (nm) x time (s) x concentration (mg/L)] followed by chemometric analysis by an appropriate PARAFAC2 or MCR-ALS second-order calibration model. The results obtained are compared with those obtained by direct determination, at maximum wavelength, and by the United States Pharmacopeia (USP) standard chromatographic method. For all the pharmaceutical formulations analysed good quantification results were found with PARAFAC2 and MCR-ALS second-order calibration models. For bulk drug analysis, detection limits of 6 and 2 mg/L, and for pharmaceutical formulations analysis, an average detection limit of 41 and 39 mg/L were found, respectively with PARAFAC2 and MCR-ALS.
Language: English
Type (Professor's evaluation): Scientific
Contact: jcsilva@fc.up.pt
No. of pages: 7
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

3-Hydroxyphenylboronic Acid-Based Carbon Dot Sensors for Fructose Sensing (2019)
Article in International Scientific Journal
Crista, DMA; Mello, GPC; Shevchuk, O; Sendao, RMS; Simoes, EFC; Leitao, JMM; da Silva, LP; Joaquim C G E Esteves da Silva
Sulfur and nitrogen co-doped carbon dots sensors for nitric oxide fluorescence quantification (2017)
Article in International Scientific Journal
Simoes, EFC; Leitao, JMM; Joaquim C G E Esteves da Silva
Simultaneous Determination of Medicinal Drugs with Overlapping Profiles Contained in Low Chromatographic Resolution Data using HPLC-DAD and Multivariate Curve Resolution (2020)
Article in International Scientific Journal
Mazivila, SJ; Joaquim C G E Esteves da Silva; Pascoa, RNMJ; Leitao, JMM

See all (16)

Of the same journal

STUDY OF AQUEOUS ACIDIC PROPERTIES OF FULVIC-ACIDS BY EVOLVING FACTOR-ANALYSIS OF PH + FT-IR TITRATION DATA (1992)
Article in International Scientific Journal
Machado, AASC; Esteves da Silva, JCG
Structural analysis of alpha-glucosidase inhibitors by validated QSAR models using topological and hydrophobicity based descriptors (2011)
Article in International Scientific Journal
Hari Narayana H N Moorthy; Maria J Ramos; Pedro A Fernandes
Segmented principal component transform-principal component analysis (2005)
Article in International Scientific Journal
Barros, AS; Rutledge, DN
Segmented principal component transform-partial least squares regression (2007)
Article in International Scientific Journal
Barros, AS; Pinto, R; Delgadillo, I; Rutledge, DN

See all (17)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-28 at 18:18:34 | Privacy Policy | Personal Data Protection Policy | Whistleblowing